tiprankstipranks
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market

ADMA Biologics (ADMA) Income Statement

Compare
2,779 Followers

ADMA Biologics Income Statement

Last quarter (Q3 2024), ADMA Biologics's total revenue was $119.84M, an increase of 78.13% from the same quarter last year. In Q3, ADMA Biologics's net income was $35.91M. See ADMA Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 258.21M$ 154.08M$ 80.94M$ 42.22M$ 29.35M
Gross Profit
$ 88.94M$ 35.27M$ 1.17M$ -19.07M$ -10.16M
Operating Expenses
$ 67.31M$ 74.63M$ 59.55M$ 45.84M$ 31.27M
Depreciation and Amortization
$ 8.33M$ 7.11M$ 5.50M$ 3.94M$ 3.26M
EBITDA
$ 5.12M$ -39.72M$ -53.33M$ -59.82M$ -36.03M
Operating Income
$ 21.63M$ -39.37M$ -58.37M$ -64.91M$ -41.42M
Other Income/Expenses
$ -49.87M$ -26.75M$ -13.51M$ -10.83M$ -6.85M
Pretax Income
$ -28.24M$ -65.90M$ -71.65M$ -75.75M$ -48.28M
Net Income
$ -28.24M$ -85.18M$ -84.45M$ -87.61M$ -57.05M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.13$ -0.43$ -0.61$ -1.02$ -1.05
Diluted EPS
$ -0.13$ -0.43$ -0.61$ -1.02$ -1.05
Weighted Average Shares Outstanding
223.98M 197.87M 139.58M 86.15M 54.35M
Weighted Average Shares Outstanding (Diluted)
223.98M 197.87M 139.58M 86.15M 54.35M
Currency in USD

ADMA Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis